|
|
 | | | |
- close
- close
- close
- close
Oncothyreon Inc (ONTY) |
StreetInsider.com
May 17
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Upgrades/Wedbush+Upgrades+Oncothyreon+%28ONTY%29+to+Outperform/8350724.html for the full story.
StreetInsider.com
Mar 14
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Oncothyreon%2C+Inc.+%28ONTY%29+Posts+Q4+Loss+of+12cShare/8184363.html for the full story.
Benzinga
Dec 19
Comment
In a report published Wednesday, Wedbush Securities downgraded its rating on Oncothyreon (NASDAQ: ONTY) from Outperform to Neutral, and lowered its price target from $31.00 to $2.00.
Wedbush Securities noted, “ONTY continues to develop...
StreetInsider.com
Dec 19
Comment
Oncothyreon Inc. (Nasdaq: ONTY) 50.8% LOWER; announced that the pivotal Phase 3 clinical trial of L-BLP25 (formerly referred to as Stimuvax) known as START did not meet its primary endpoint of an improvement in overall survival in patients with...
StreetInsider.com
Nov 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Oncothyreon%2C+Inc.+%28ONTY%29+Reports+In-Line+Q3+EPS/7854756.html for the full story.
Benzinga
Oct 24
Comment
The Food and Drug Administration Commissioner Margaret Hamburg has told scientific advisers that the FDA is considering a faster pathway for obesity treatments, life-saving antibiotics and other drugs deemed to offer societal benefit. The Paragon...
MarketWatch
Aug 24
Comment
Shares of Oncothyreon Inc. jumped 11% to $4.84 on Friday after analysts at Stifel Nicolaus initiated coverage of the stock with a buy rating and price target of $10. The stock has climbed 17% over the last 30 days, but has fallen 36% since the...
StreetInsider.com
Aug 9
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Oncothyreon%2C+Inc.+%28ONTY%29+Posts+Wider+than+Expected+Q2+Loss+of+15cShare/7646603.html for the full story.
Marketwire
Jul 17
Comment
NEW YORK, NY -- (Marketwire) -- 07/17/12 -- The Biotechnology Industry has been soaring in 2012 as companies -- both large and small -- have shown impressive growth. The SPDR S&P Biotech ETF (XBI) and the First Trust NYSE Arca Biotech Index ETF (FBT)
StreetInsider.com
Jun 21
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Oncothyreon+%28ONTY%29+Names+Scott+Peterson+as+CSO/7532844.html for the full story.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
